Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part 1.1 Analytical techniques: analysis of DNA
- Part 1.2 Analytical techniques: analysis of RNA
- Part 2.1 Molecular pathways underlying carcinogenesis: signal transduction
- Part 2.2 Molecular pathways underlying carcinogenesis: apoptosis
- Part 2.3 Molecular pathways underlying carcinogenesis: nuclear receptors
- Part 2.4 Molecular pathways underlying carcinogenesis: DNA repair
- Part 2.5 Molecular pathways underlying carcinogenesis: cell cycle
- Part 2.6 Molecular pathways underlying carcinogenesis: other pathways
- Part 3.1 Molecular pathology: carcinomas
- Part 3.2 Molecular pathology: cancers of the nervous system
- 57 Brain tumors
- 58 Mechanisms of pituitary tumorigenesis
- 59 Molecular oncology of neuroblastoma
- 60 Neurofibromatosis type I
- Part 3.3 Molecular pathology: cancers of the skin
- Part 3.4 Molecular pathology: endocrine cancers
- Part 3.5 Molecular pathology: adult sarcomas
- Part 3.6 Molecular pathology: lymphoma and leukemia
- Part 3.7 Molecular pathology: pediatric solid tumors
- Part 4 Pharmacologic targeting of oncogenic pathways
- Index
- References
58 - Mechanisms of pituitary tumorigenesis
from Part 3.2 - Molecular pathology: cancers of the nervous system
Published online by Cambridge University Press: 05 February 2015
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part 1.1 Analytical techniques: analysis of DNA
- Part 1.2 Analytical techniques: analysis of RNA
- Part 2.1 Molecular pathways underlying carcinogenesis: signal transduction
- Part 2.2 Molecular pathways underlying carcinogenesis: apoptosis
- Part 2.3 Molecular pathways underlying carcinogenesis: nuclear receptors
- Part 2.4 Molecular pathways underlying carcinogenesis: DNA repair
- Part 2.5 Molecular pathways underlying carcinogenesis: cell cycle
- Part 2.6 Molecular pathways underlying carcinogenesis: other pathways
- Part 3.1 Molecular pathology: carcinomas
- Part 3.2 Molecular pathology: cancers of the nervous system
- 57 Brain tumors
- 58 Mechanisms of pituitary tumorigenesis
- 59 Molecular oncology of neuroblastoma
- 60 Neurofibromatosis type I
- Part 3.3 Molecular pathology: cancers of the skin
- Part 3.4 Molecular pathology: endocrine cancers
- Part 3.5 Molecular pathology: adult sarcomas
- Part 3.6 Molecular pathology: lymphoma and leukemia
- Part 3.7 Molecular pathology: pediatric solid tumors
- Part 4 Pharmacologic targeting of oncogenic pathways
- Index
- References
Summary
Introduction
The pituitary, a small bean-shaped gland at the base of the brain, maintains multiple homeostatic functions, including metabolism, growth, and reproduction. Most pituitary tumors are adenomas that develop in the adenohypophysis, the epithelial anterior lobe composed of six cell types that secrete polypeptide hormones.
Pituitary adenomas exhibit a wide range of hormonal and proliferative behaviors (1). They may be small, slowly growing and hormonally inactive, detected as radiographic “incidentalomas” or at post-mortem examination. When they produce hormones in excess, they cause mood disorders, sexual dysfunction, infertility, obesity and disfigurement, hypertension, diabetes mellitus, and accelerated heart disease. Untreated, hormone excess syndromes can be associated with diminished survival.
Some pituitary adenomas grow rapidly, producing symptoms of an intra-cranial mass, loss of normal anterior pituitary hormone production, and visual ield disturbances due to stretching of the overlying optic chiasm.hey can invade downward into paranasal sinuses, laterally into the cavernous sinuses (thereby disrupting co-ordinated eye movement) and upwards into the brain.hey can cause death by invasion of brain.
Early studies using X-chromosome inactivation proved that these adenomas are monoclonal neoplasms (2–5). Polyclonal results were attributed to contamination by normal tissue; the small adenomas associated with Cushing’s syndrome are particularly subject to this phenomenon (4,5).
- Type
- Chapter
- Information
- Molecular OncologyCauses of Cancer and Targets for Treatment, pp. 652 - 668Publisher: Cambridge University PressPrint publication year: 2013